Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia

BACKGROUND: The purpose of this study was to review the treatment plan of patients with multidrug-resistant Acinetobacter baumannii (MDR-AB) pneumonia and analyze the factors associated with patient deaths and the medication regimen. METHODS: We collected 1,823 qualified respiratory specimens that w...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yanling, Chen, Lin, Yue, Mingrui, Huang, Xiaobo, Yang, Yang, Yu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585752/
https://www.ncbi.nlm.nih.gov/pubmed/36271362
http://dx.doi.org/10.1186/s12879-022-07778-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585752/
https://www.ncbi.nlm.nih.gov/pubmed/36271362
http://dx.doi.org/10.1186/s12879-022-07778-5

Ejemplares similares